Acute Heart Failure (AHF)B-AHFNCT07601022
Acute Heart Failure Registry
An observational study of Acute Heart Failure (AHF), run by Jin Joo Park at 1 site in South Korea.
Trial summary
To evaluate the clinical utility of quantitative electrocardiography (Quantitative ECG, QCG) by analyzing its associations with clinical characteristics and laboratory findings in patients hospitalized with acute heart failure. Read more about this study
- Who is it for?
- Ages 19 years and older
- Conditions the study is for
- Acute Heart Failure (AHF)
- How many people
- 400 participants
- Where
- 1 siteSouth Korea
- Study dates
- 8 May 2026to 31 Dec 2030
- How long will I take part?
- 1 Year
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients with acute heart failure who were admitted to the hospital
Who may be able to join
- Adults aged 19 years or older who were admitted to the Department of Cardiology for acute heart failure
- NT-proBNP ≥300 pg/mL
- Patients who underwent electrocardiography at least once
Who cannot join
- History of congenital heart disease
- Patients with a dominant electronic pacemaker rhythm
- Patients with a heart rate >140 beats per minute or electrocardiograms with excessive noise
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
South Korea1 site, 1 recruiting
- Recruiting
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 13620
Jin Joo Park, MD, PhD, +82-317877074, jinjooparkmd@gmail.com
Minjae Yoon, MD, +82317877854, minjae1677@gmail.com
About this study
Official title: Clinical Utility of Quantitative Electrocardiography in Patients With Acute Heart Failure: A Prospective Observational Study
To evaluate the clinical utility of quantitative electrocardiography (Quantitative ECG, QCG) by analyzing its associations with clinical characteristics and laboratory findings in patients hospitalized with acute heart failure.
- Conditions
- Acute Heart Failure (AHF)
- Keywords
- acute heart failure, heart failure, electrocardiography
- Medical subject headings
- Heart Failure
What is being measured
The primary outcome is the main question the study is designed to answer.
1-year mortality
Measured: From enrollment to 1-year
Secondary outcomes (1)
LVEF change
LVEF change by echocardiography
Measured: From enrollment to 1-year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 May 2026
- Study start8 May 2026
- Primary completion31 Dec 2030 (estimated)
- Study completion31 Dec 2030 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Acute Heart Failure (AHF)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 400 participants (estimated)
- Target duration
- 1 Year
Sponsor and investigators
- Lead sponsor
- Jin Joo Park
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Jin Joo Park, Seoul National University Bundang Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07601022
- Sponsor's protocol ID
- B-2512-1016-301
- Acronym
- B-AHF
- Status last verified
- May 2026
- First submitted
- 15 May 2026
- Last updated
- 1 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical Utility of Quantitative Electrocardiography in Patients With Acute Heart Failure: A Prospective Observational Study
- ClinicalTrials.gov ID
- NCT07601022
- Acronym / sponsor ID
- B-AHF / B-2512-1016-301
- Conditions
- Acute Heart Failure (AHF)
- Keywords
- acute heart failure, heart failure, electrocardiography
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 400 participants (estimated)
- Lead sponsor
- Jin Joo ParkUniversity, hospital or other
- Study start
- 8 May 2026 (actual)
- Primary completion
- 31 Dec 2030 (estimated)
- Study completion
- 31 Dec 2030 (estimated)
- First posted
- 22 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To evaluate the clinical utility of quantitative electrocardiography (Quantitative ECG, QCG) by analyzing its associations with clinical characteristics and laboratory findings in patients hospitalized with acute heart failure.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 1 Year
Who may qualify
- Ages
- 19 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with acute heart failure who were admitted to the hospital
Key inclusion criteria (3 listed)
- Adults aged 19 years or older who were admitted to the Department of Cardiology for acute heart failure
- NT-proBNP ≥300 pg/mL
- Patients who underwent electrocardiography at least once
Key exclusion criteria (3 listed)
- History of congenital heart disease
- Patients with a dominant electronic pacemaker rhythm
- Patients with a heart rate >140 beats per minute or electrocardiograms with excessive noise
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
1-year mortality
Time frame: From enrollment to 1-year
1 secondary outcome
LVEF change
Time frame: From enrollment to 1-year
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Jun 2026.
- Individual participant dataSharing planned: No
Related trials for Acute Heart Failure (AHF)
RecruitingPhase 4
DECONGEST-AHF: Vasodilatation or Loop Diuretics in Acute Heart Failure
Pulmonary Edema, Congestive Heart Failure
Enrolling by invitation
Implementation of Acute Heart Failure Checklist
Acute Heart Failure (AHF), Implementation Research
RecruitingObservational study
Urinary Chloride and Sodium Changes and Residual Congestion in Acute Heart Failure
Acute Heart Failure (AHF), Heart Failure
RecruitingPhase 2/3
Randomized Evaluation of Istaroxime for Stabilization in Acute Heart Failure-Cardiogenic Shock
Cardiogenic Shock
Not yet recruitingObservational study
Risk Factors, Etiology and Predictable Outcomes With Risk Stratification Scores in Acute Heart Failure Patients
Acute Heart Failure (AHF)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Seoul National University Bundang Hospital
Seongnam-si, South Korea
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Acute Heart Failure (AHF), run by Jin Joo Park at 1 site in South Korea.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 1 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
1-year mortality (time frame: From enrollment to 1-year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jun 2026.